Paclitaxel Shows Promise: A Viable Alternative to Cisplatin in Ovarian Cancer HIPEC

2025-07-07
Paclitaxel Shows Promise: A Viable Alternative to Cisplatin in Ovarian Cancer HIPEC
Medscape

For years, cisplatin has been a cornerstone of treatment for advanced ovarian cancer, particularly within the context of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). However, the potential for severe side effects and the desire for alternative ...Leer más

Recomendaciones
Recomendaciones